There have been other studies that have shown that MK2 plays a regulatory role in fibrotic responses by modulating fibroblast activity and extracellular matrix production in pulmonary fibrosis and mesenchymal cells in chronic inflammatory bowel disease models [46,47]. Here, MAPKAPK2 is linked to pulmonary fibrosis.